research communications\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

Synthesis and crystal structure of (2E)-1-[3,5-bis­­(benz­yl­oxy)phen­yl]-3-(4-eth­­oxy­phen­yl)prop-2-en-1-one

crossmark logo

aDepartment of Chemistry, Annamalai University, Annamalainagar, Chidambaram 608 002, India, bDepartment of Chemistry, Sri Chandrasekharendra Saraswathi Viswa Mahavidyalaya, (Deeded to be University), Kanchipuram 631 561, India, cPG & Research Department of Physics, Government Arts College, Melur 625 106, India, and dNanosciences/Nanotechnology Laboratories, University of South Africa (UNISA), Pretoria, South Africa
*Correspondence e-mail: profmani.au@gmail.com

Edited by W. T. A. Harrison, University of Aberdeen, United Kingdom (Received 8 July 2024; accepted 31 July 2024; online 6 August 2024)

In the title compound, C31H28O4, the phenyl rings of the chalcone unit subtend a dihedral angle of 26.43 (10)°. The phenyl rings of the pendant benz­yloxy groups are orientated at 75.57 (13) and 75.70 (10)° with respect to their attached ring. In the crystal, weak C—H⋯O and C—H⋯π inter­actions link the mol­ecules. The inter­molecular inter­actions were qu­anti­fied and analysed using Hirshfeld surface analysis, which showed a breakdown into H⋯H (49.8%), H⋯C/C⋯H (33.8%) and H⋯O/O⋯H (13.6%) inter­actions with other types making negligible contributions.

1. Chemical context

Chalcones incorporate an α,β-unsaturated carbonyl (enone) bridge connecting two aromatic rings. The chalcone scaffold exhibits anti-cancer efficacy on various human cancer cells (Zhuang et al., 2017[Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C. & Miao, Z. (2017). Chem. Rev. 117, 7762-7810.]; Liu et al., 2022[Liu, W., He, M., Li, Y., Peng, Z. & Wang, G. (2022). J. Enzyme Inhib. Med. Chem. 37, 9-38.]). DrugBank lists three chalcone-based drugs namely hesperidin methyl­chalcone (DrugBank: DB15943), di­hydroxy­meth­oxy­chalcone (DB14122) and 3-(4-hy­droxy­phen­yl)prop-2-en-1-one (DB07500). In general, the anti­cancer efficacy of chalcones is enhanced by attaching different substitutents at ring A of the chalcone, which is attached to the C=O group (Mai et al., 2014[Mai, C. W., Yaeghoobi, M., Abd-Rahman, N., Kang, Y. B. & Pichika, M. R. (2014). Eur. J. Med. Chem. 77, 378-387.]). As part of our studies in this area, we have prepared and undertaken a single-crystal X-ray diffraction study of the title compound, C31H28O4, (I)[link], and the results are presented here.

[Scheme 1]

2. Structural commentary

The mol­ecular structure of (I)[link] is illustrated in Fig. 1[link]. The C12–C17 and C19–C24 phenyl rings of the chalcone unit subtend a dihedral angle of 26.43 (10)°: the most significant twist occurs about the C11—C12 bond, as indicated by the C10—C11—C12—C13 torsion angle of −13.0 (3)°. The dihedral angles between the C19–C24 and C26–C31 pendant phenyl rings and their attached C12–C17 ring are 75.57 (13) and 75.70 (10)°, respectively. The C3—O1—C2—C1, C14—O4—C25—C26 and C16—O3—C18—C19 torsion angles of 177.2 (3), 176.21 (18) and 179.5 (2)°, respectively, indicate an anti conformation in each case.

[Figure 1]
Figure 1
The mol­ecular structure of (I)[link] with displacement ellipsoids drawn at the 30% probability level.

3. Supra­molecular features

In the crystal of (I)[link], the mol­ecules associate via weak C—H⋯O inter­actions (Table 1[link]), forming C(15) chains propagating along [101] (Fig. 2[link]). In addition, inversion-related mol­ecules are linked by pairwise weak C—H⋯π inter­actions (Fig. 3[link]).

Table 1
Hydrogen-bond geometry (Å, °)

Cg1 is the centroid of the C26–C31 ring.

D—H⋯A D—H H⋯A DA D—H⋯A
C1—H1A⋯O4i 0.96 2.64 3.227 (3) 119
C25—H25BCg1ii 0.97 2.68 3.398 (2) 132
Symmetry codes: (i) [x-1, y, z-1]; (ii) [-x+1, -y, -z+1].
[Figure 2]
Figure 2
Detail of the packing of (I)[link] showing C—H⋯O inter­actions as dashed lines. For clarity H atoms not involved in these hydrogen bonds have been omitted.
[Figure 3]
Figure 3
Detail of the packing of (I)[link] showing C—H⋯π inter­actions as dashed lines.

4. Hirshfeld surface analysis

To further characterize the inter­molecular inter­actions in (I)[link], a Hirshfeld surface analysis was performed using Crystal Explorer 21 (Spackman et al., 2021[Spackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D. & Spackman, M. A. (2021). J. Appl. Cryst. 54, 1006-1011.]) and the associated two dimensional fingerprint plots were generated. The HS mapped over dnorm in the range −0.09 to +1.53 a.u. is illustrated in Fig. 4[link], using colours to indicate contacts that are shorter (red areas), equal to (white areas), or longer than (blue areas) the sum of the van der Waals radii (Ashfaq et al., 2021[Ashfaq, M., Tahir, M. N., Muhammad, S., Munawar, K. S., Ali, A., Bogdanov, G. & Alarfaji, S. S. (2021). ACS Omega, 6, 31211-31225.]).

[Figure 4]
Figure 4
A view of the Hirshfeld surface mapped over dnorm for (I)[link].

The overall two-dimensional fingerprint plot, Fig. 5[link]a, and those delineated into H⋯H inter­actions (49.8%), H⋯C/C⋯H (33.8%), H⋯O/O⋯H (13.6%), C⋯C (1.8%) and O⋯C/C⋯O (1%) inter­actions are illustrated in Fig. 5[link]bf, respectively, together with their relative contributions to the HS. The most important inter­action is H⋯H, which is reflected in Fig. 5[link]b as widely scattered points of high density due to the large hydrogen content of the mol­ecule with the tip at de = di = 1.10 Å. As a result of the presence of C—H⋯O inter­actions, the H⋯O/O⋯H contacts contribute 13.6% to the overall crystal packing, as reflected in Fig. 5[link]d with the tips at de + di = 2.50 Å.

[Figure 5]
Figure 5
Two-dimensional fingerprint plots for (I)[link], showing (a) all inter­actions, and delineated into (b) H⋯H, (c) H⋯C/C⋯H, (d) H⋯O/O⋯H, (e) C⋯C and (f) O⋯C/C⋯O inter­actions.

5. Synthesis and crystallization

Equimolar concentrations of 3,5-di­benzyl­oxyaceto­phenone and 4-eth­oxy­benzaldehyde were dissolved in ethanol in separate reaction flasks and then mixed. Drop by drop, utilizing a magnetic stirring device, 2 ml of 10% sodium hydroxide in water were introduced at room temperature. The course of the process was tracked using thin-layer chromatography. After the process was complete, the resulting product was placed on crushed ice. The finished product was vacuum-filtered, dried, and then recrystallized from ethanol solution to yield colourless blocks of the title compound.

IR (cm−1): 3032 aromatic C—H stretch, 2934 and 2875 aliphatic C—H stretch, 1651 C=O stretch, 1568 aromatic ring C=C stretch (see table in the supporting information).

6. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2[link]. H atoms were placed in idealized positions and allowed to ride on their parent atoms: C—H = 0.93–0.97 Å, with Uiso(H) = 1.5Ueq(C-meth­yl) and 1.2Ueq(C) for other H atoms.

Table 2
Experimental details

Crystal data
Chemical formula C31H28O4
Mr 464.53
Crystal system, space group Triclinic, P[\overline{1}]
Temperature (K) 298
a, b, c (Å) 9.0494 (9), 10.0326 (11), 14.6932 (15)
α, β, γ (°) 100.153 (3), 107.292 (3), 90.789 (4)
V3) 1250.6 (2)
Z 2
Radiation type Mo Kα
μ (mm−1) 0.08
Crystal size (mm) 0.31 × 0.23 × 0.19
 
Data collection
Diffractometer Bruker D8 Quest XRD
Absorption correction
No. of measured, independent and observed [I > 2σ(I)] reflections 30243, 5428, 3607
Rint 0.037
(sin θ/λ)max−1) 0.638
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.057, 0.178, 1.05
No. of reflections 5428
No. of parameters 317
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.36, −0.18
Computer programs: APEX3 and SAINT (Bruker, 2017[Bruker (2017). APEX2, and SAINT. Bruker AXS Inc., Madison, Wisconsin, U. S. A.]), SHELXT2018/2 (Sheldrick, 2015a[Sheldrick, G. M. (2015a). Acta Cryst. A71, 3-8.]), SHELXL2019/3 (Sheldrick, 2015b[Sheldrick, G. M. (2015b). Acta Cryst. C71, 3-8.]), ORTEP-3 for Windows (Farrugia, 2012[Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.]) and PLATON (Spek, 2020[Spek, A. L. (2020). Acta Cryst. E76, 1-11.]).

Supporting information


Footnotes

Additional correspondence author, e-mail: s_selvanayagam@rediffmail.com.

References

First citationAshfaq, M., Tahir, M. N., Muhammad, S., Munawar, K. S., Ali, A., Bogdanov, G. & Alarfaji, S. S. (2021). ACS Omega, 6, 31211–31225.  Web of Science CSD CrossRef CAS PubMed Google Scholar
First citationBruker (2017). APEX2, and SAINT. Bruker AXS Inc., Madison, Wisconsin, U. S. A.  Google Scholar
First citationFarrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationLiu, W., He, M., Li, Y., Peng, Z. & Wang, G. (2022). J. Enzyme Inhib. Med. Chem. 37, 9–38.  Web of Science CrossRef PubMed Google Scholar
First citationMai, C. W., Yaeghoobi, M., Abd-Rahman, N., Kang, Y. B. & Pichika, M. R. (2014). Eur. J. Med. Chem. 77, 378–387.  Web of Science CrossRef CAS PubMed Google Scholar
First citationSheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.  Web of Science CrossRef IUCr Journals Google Scholar
First citationSheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.  Web of Science CrossRef IUCr Journals Google Scholar
First citationSpackman, P. R., Turner, M. J., McKinnon, J. J., Wolff, S. K., Grimwood, D. J., Jayatilaka, D. & Spackman, M. A. (2021). J. Appl. Cryst. 54, 1006–1011.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationSpek, A. L. (2020). Acta Cryst. E76, 1–11.  Web of Science CrossRef IUCr Journals Google Scholar
First citationZhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C. & Miao, Z. (2017). Chem. Rev. 117, 7762–7810.  Web of Science CrossRef CAS PubMed Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds